|
|
|
Insider
Information: |
Bienaime Jean Jacques |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
540,054 |
|
Indirect Shares
|
247,533 |
|
|
Direct
Value |
$43,092,104 |
|
|
Indirect Value
|
$21,938,850 |
|
|
Total
Shares |
787,587 |
|
|
Total
Value |
$65,030,954 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
1
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
1
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-13.1%
|
-5.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2024-05-20 |
473,792 |
2024-05-20 |
247,533 |
Premium* |
|
Neurogesx Inc |
NGSX |
Director |
2011-07-26 |
21,748 |
|
0 |
Premium* |
|
InterMune Inc |
ITMN |
Director |
2014-09-29 |
0 |
2012-04-06 |
0 |
Premium* |
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2014-05-16 |
706 |
2013-05-28 |
0 |
Premium* |
|
Immunic Inc |
IMUX |
Director |
2018-09-24 |
18,500 |
2001-04-23 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2023-06-14 |
15,493 |
|
0 |
Premium* |
|
Immunome Inc. |
IMNM |
|
2024-05-21 |
9,615 |
|
0 |
Premium* |
|
Keros Therapeutics, Inc. |
KROS |
|
2024-06-01 |
200 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
853 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 7 of 35
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-01-02 |
4 |
OE |
$6.46 |
$96,900 |
D/D |
15,000 |
22,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-05-08 |
4 |
B |
$12.78 |
$12,778 |
D/D |
1,000 |
22,881 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-03-04 |
4 |
OE |
$12.99 |
$64,950 |
I/I |
5,000 |
23,545 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-05-18 |
4 |
B |
$12.00 |
$12,000 |
D/D |
1,000 |
23,881 |
2.81 |
- |
|
NGSX |
Neurogesx Inc |
Director |
|
2009-08-14 |
4 |
S |
$7.18 |
$18,991 |
D/D |
(2,621) |
24,740 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Director |
|
2008-05-20 |
4 |
B |
$3.48 |
$31,571 |
D/D |
9,000 |
24,821 |
2.39 |
- |
|
IMUX |
Immunic Inc |
Director |
|
2014-10-08 |
4 |
B |
$17.50 |
$75,005 |
D/D |
4,286 |
25,119 |
2.39 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-02-29 |
4 |
OE |
$6.46 |
$116,280 |
D/D |
18,000 |
25,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-06-01 |
4 |
AB |
$13.05 |
$19,575 |
D/D |
1,500 |
25,381 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-03-26 |
4 |
OE |
$12.99 |
$155,880 |
I/I |
12,000 |
25,545 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-16 |
4 |
OE |
$12.99 |
$349,247 |
I/I |
7,000 |
25,609 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-06-01 |
4 |
OE |
$6.46 |
$64,600 |
D/D |
10,000 |
25,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-11-30 |
4 |
AS |
$94.74 |
$94,744 |
I/I |
(1,000) |
25,758 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-09-28 |
4 |
OE |
$6.46 |
$124,077 |
D/D |
19,207 |
25,902 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-05-05 |
4 |
OE |
$6.46 |
$32,300 |
D/D |
5,000 |
26,120 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2007-10-01 |
4 |
OE |
$6.46 |
$5,123 |
D/D |
793 |
26,695 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-10-15 |
4 |
AS |
$108.24 |
$108,241 |
I/I |
(1,000) |
26,758 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2008-03-03 |
4 |
OE |
$6.46 |
$12,920 |
D/D |
2,000 |
27,213 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-09-14 |
4 |
AS |
$131.43 |
$131,432 |
I/I |
(1,000) |
27,758 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Director |
|
2008-05-21 |
4 |
B |
$3.53 |
$10,619 |
D/D |
3,000 |
27,821 |
2.39 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-06-14 |
4 |
B |
$13.15 |
$33,090 |
D/D |
2,500 |
27,881 |
2.81 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2013-05-13 |
4 |
OE |
$12.99 |
$103,920 |
I/I |
8,000 |
28,609 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2015-08-12 |
4 |
AS |
$134.72 |
$202,083 |
I/I |
(1,500) |
28,758 |
0 |
- |
|
NGSX |
Neurogesx Inc |
Director |
|
2008-12-01 |
4 |
B |
$1.21 |
$1,458 |
D/D |
1,200 |
29,021 |
2.31 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
Chief Executive Officer |
|
2006-07-03 |
4 |
AB |
$14.44 |
$21,660 |
D/D |
1,500 |
29,381 |
2.81 |
- |
|
853 Records found
|
|
Page 7 of 35 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|